Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

被引：77

作者：

Couch, Fergus J. ^{[1
,2
]}

Kuchenbaecker, Karoline B. ^{[3
]}

Michailidou, Kyriaki ^{[3
]}

Mendoza-Fandino, Gustavo A. ^{[4
]}

Nord, Silje ^{[5
]}

Lilyquist, Janna ^{[2
]}

Olswold, Curtis ^{[2
]}

Hallberg, Emily ^{[2
]}

Agata, Simona ^{[6
]}

Ahsan, Habibul ^{[7
,8
,9
]}

Aittomaeki, Kristiina ^{[10
]}

Ambrosone, Christine ^{[11
]}

Andrulis, Irene L. ^{[12
,13
,14
]}

Anton-Culver, Hoda ^{[15
]}

Arndt, Volker ^{[16
]}

Arun, Banu K. ^{[17
]}

Arver, Brita ^{[18
]}

Barile, Monica ^{[19
]}

Barkardottir, Rosa B. ^{[20
,21
]}

Barrowdale, Daniel ^{[3
]}

Beckmann, Lars ^{[22
]}

Beckmann, Matthias W. ^{[23
]}

Benitez, Javier ^{[24
,25
,26
]}

Blank, Stephanie V. ^{[27
]}

Blomqvist, Carl ^{[28
,29
]}

Bogdanova, Natalia V. ^{[30
]}

Bojesen, Stig E. ^{[31
]}

Bolla, Manjeet K. ^{[3
]}

Bonanni, Bernardo ^{[19
]}

Brauch, Hiltrud ^{[32
,33
]}

Brenner, Hermann ^{[16
,34
,35
]}

Burwinkel, Barbara ^{[36
]}

Buys, Saundra S. ^{[37
]}

Caldes, Trinidad ^{[38
]}

Caligo, Maria A. ^{[39
,40
]}

Canzian, Federico ^{[41
]}

Carpenter, Jane ^{[42
]}

Chang-Claude, Jenny ^{[43
]}

Chanock, Stephen J. ^{[44
]}

Chung, Wendy K. ^{[45
,46
]}

Claes, Kathleen B. M. ^{[47
]}

Cox, Angela ^{[48
]}

Cross, Simon S. ^{[49
]}

Cunningham, Julie M. ^{[1
]}

Czene, Kamila ^{[50
]}

Daly, Mary B. ^{[51
]}

Damiola, Francesca ^{[52
]}

Darabi, Hatef ^{[50
]}

de la Hoya, Miguel ^{[38
]}

Devilee, Peter ^{[53
]}

机构：

[1] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA

[2] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA

[3] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge CB1 8RN, England

[4] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Canc Epidemiol Program, Tampa, FL 33612 USA

[5] Radiumhosp, Oslo Univ Hosp, Inst Canc Res, Dept Genet, N-0310 Oslo, Norway

[6] IRCCS, IOV, Immunol & Mol Oncol Unit, I-20133 Padua, Italy

[7] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA

[8] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA

[9] Univ Chicago, Dept Med & Human Genet, Chicago, IL 60637 USA

[10] Univ Helsinki, Cent Hosp, Dept Clin Genet, Helsinki 00029, Finland

[11] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA

[12] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada

[13] Univ Toronto, Dept Mol Genet, Toronto, ON M5B 1W8, Canada

[14] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5B 1W8, Canada

[15] Univ Calif Irvine, Dept Epidemiol, Irvine, CA 92697 USA

[16] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany

[17] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[18] Karolinska Univ Hosp, Dept Oncol, SE-17176 Stockholm, Sweden

[19] Ist Europeo Oncol, Div Canc Prevent & Genet, I-20141 Milan, Italy

[20] Landspitali Univ Hosp, Dept Pathol, IS-101 Reykjavik, Iceland

[21] Univ Iceland, Sch Med, IS-101 Reykjavik, Iceland

[22] Inst Qual & Efficiency Hlth Care IQWiG, D-50670 Cologne, Germany

[23] Univ Erlangen Nurnberg, Comprehens Canc Ctr Erlangen EMN, Univ Breast Ctr Franconia, Dept Gynecol & Obstet,Univ Hosp Erlangen, D-91054 Erlangen, Germany

[24] Spanish Natl Canc Ctr CNIO, Human Genet Grp, Human Canc Genet Program, Madrid 28029, Spain

[25] Spanish Natl Canc Ctr CNIO, Human Canc Genet Program, Genotyping Unit CeGen, Madrid 28029, Spain

[26] Biomed Network Rare Dis CIBERER, Madrid 28029, Spain

[27] NYU, Sch Med, NYU Womens Canc Program, New York, NY 10016 USA

[28] Univ Helsinki, Dept Oncol, FI-00029 Helsinki, Finland

[29] Univ Helsinki, Cent Hosp, FI-00029 Helsinki, Finland

[30] Hannover Med Sch, Dept Radiat Oncol, D-30625 Hannover, Germany

[31] Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, DK-2730 Herlev, Denmark

[32] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany

[33] Univ Tubingen, D-72074 Tubingen, Germany

[34] German Canc Res Ctr, Div Prevent Oncol, D-69120 Heidelberg, Germany

[35] Natl Ctr Tumor Dis NCT, D-69120 Heidelberg, Germany

[36] Heidelberg Univ, Dept Obstet & Gynecol, D-69120 Heidelberg, Germany

[37] Univ Utah, Sch Med, Dept Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[38] IdISSC, Hosp Clin San Carlos, Mol Oncol Lab, Madrid 28040, Spain

[39] Univ Pisa, Dept Lab Med, Sect Genet Oncol, I-56126 Pisa, Italy

[40] Univ Hosp Pisa, I-56126 Pisa, Italy

[41] German Canc Res Ctr, Genom Epidemiol Grp, D-69120 Heidelberg, Germany

[42] Univ Sydney, Westmead Millennium Inst, Australian Breast Canc Tissue Bank, Sydney, NSW 2145, Australia

[43] German Canc Res Ctr, Div Canc Epidemiol, D-69120 Heidelberg, Germany

[44] NCI, Div Canc Epidemiol & Genet, Rockville, MD 20850 USA

[45] Columbia Univ, Dept Pediat, New York, NY 10032 USA

[46] Columbia Univ, Dept Med, New York, NY 10032 USA

[47] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium

[48] Univ Sheffield, Dept Oncol, Sheffield Canc Res Ctr, Sheffield S10 2RX, S Yorkshire, England

[49] Univ Sheffield, Acad Unit Pathol, Dept Neurosci, Sheffield S10 2HQ, S Yorkshire, England

[50] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden

来源：

NATURE COMMUNICATIONS | 2016年 / 7卷

基金：

美国国家卫生研究院; 加拿大健康研究院;

关键词：

GENOME-WIDE ASSOCIATION; BRCA2 MUTATION CARRIERS; GENE-EXPRESSION; COMMON VARIANTS; TELOMERE LENGTH; RISK; IDENTIFY; INVESTIGATORS; METAANALYSIS; CONSORTIUM;

D O I：

10.1038/ncomms11375

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Common variants in 94 loci have been associated with breast cancer including 15 loci with genome-wide significant associations (P<5 x 10(-8)) with oestrogen receptor (ER)-negative breast cancer and BRCA1-associated breast cancer risk. In this study, to identify new ER-negative susceptibility loci, we performed a meta-analysis of 11 genome-wide association studies (GWAS) consisting of 4,939 ER-negative cases and 14,352 controls, combined with 7,333 ER-negative cases and 42,468 controls and 15,252 BRCA1 mutation carriers genotyped on the iCOGS array. We identify four previously unidentified loci including two loci at 13q22 near KLF5, a 2p23.2 locus near WDR43 and a 2q33 locus near PPIL3 that display genome-wide significant associations with ER-negative breast cancer. In addition, 19 known breast cancer risk loci have genome-wide significant associations and 40 had moderate associations (P<0.05) with ER-negative disease. Using functional and eQTL studies we implicate TRMT61B and WDR43 at 2p23.2 and PPIL3 at 2q33 in ER-negative breast cancer aetiology. All ER-negative loci combined account for similar to 11% of familial relative risk for ER-negative disease and may contribute to improved ER-negative and BRCA1 breast cancer risk prediction.

引用

页数：13

共 50 条

[1] Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
Fergus J. Couch
Karoline B. Kuchenbaecker
Kyriaki Michailidou
Gustavo A. Mendoza-Fandino
Silje Nord
Janna Lilyquist
Curtis Olswold
Emily Hallberg
Simona Agata
Habibul Ahsan
Kristiina Aittomäki
Christine Ambrosone
Irene L. Andrulis
Hoda Anton-Culver
Volker Arndt
Banu K. Arun
Brita Arver
Monica Barile
Rosa B. Barkardottir
Daniel Barrowdale
Lars Beckmann
Matthias W. Beckmann
Javier Benitez
Stephanie V. Blank
Carl Blomqvist
Natalia V. Bogdanova
Stig E. Bojesen
Manjeet K. Bolla
Bernardo Bonanni
Hiltrud Brauch
Hermann Brenner
Barbara Burwinkel
Saundra S. Buys
Trinidad Caldes
Maria A. Caligo
Federico Canzian
Jane Carpenter
Jenny Chang-Claude
Stephen J. Chanock
Wendy K. Chung
Kathleen B. M. Claes
Angela Cox
Simon S. Cross
Julie M. Cunningham
Kamila Czene
Mary B. Daly
Francesca Damiola
Hatef Darabi
Miguel de la Hoya
Peter Devilee
Nature Communications, 7
[2] The origins of oestrogen receptor negative breast cancer
D Craig Allred
Breast Cancer Research, 9
[3] The origins of oestrogen receptor negative breast cancer
Allred, D. Craig
BREAST CANCER RESEARCH, 2007, 9 (Suppl 2)
[4] Chemotherapy for oestrogen-receptor-negative breast cancer
Yerushalmi, Rinat
Gelmon, Karen
LANCET, 2008, 371 (9606): : 4 - 5
[5] Identification of novel nuclear receptor targets in estrogen receptor negative breast cancer
Covington, Kyle R.
Gu, Guowei
Tsimelzon, Anna
Hilsenbeck, Susan
Brown, Powel
Change, Jenny
Osborne, C. Kent
Xu, Jianming
O'Malley, Bert
Mangelsdorf, David
Minna, John
Fuqua, Suzanne
CANCER RESEARCH, 2011, 71
[6] Common Breast Cancer Susceptibility Loci Are Associated with Triple-Negative Breast Cancer
Stevens, Kristen N.
Vachon, Celine M.
Lee, Adam M.
Slager, Susan
Lesnick, Timothy
Olswold, Curtis
Fasching, Peter A.
Miron, Penelope
Eccles, Diana
Carpenter, Jane E.
Godwin, Andrew K.
Ambrosone, Christine
Winqvist, Robert
Brauch, Hiltrud
Schmidt, Marjanka K.
Cox, Angela
Cross, Simon S.
Sawyer, Elinor
Hartmann, Arndt
Beckmann, Matthias W.
Schulz-Wendtland, Ruediger
Ekici, Arif B.
Tapper, William J.
Gerty, Susan M.
Durcan, Lorraine
Graham, Nikki
Hein, Rebecca
Nickels, Stephan
Flesch-Janys, Dieter
Heinz, Judith
Sinn, Hans-Peter
Konstantopoulou, Irene
Fostira, Florentia
Pectasides, Dimitrios
Dimopoulos, Athanasios M.
Fountzilas, George
Clarke, Christine L.
Balleine, Rosemary
Olson, Janet E.
Fredericksen, Zachary
Diasio, Robert B.
Pathak, Harsh
Ross, Eric
Weaver, JoEllen
Ruediger, Thomas
Forsti, Asta
Duennebier, Thomas
Ademuyiwa, Foluso
Kulkarni, Swati
Pylkaes, Katri
CANCER RESEARCH, 2011, 71 (19) : 6240 - 6249
[7] Pathway Based Analysis of Oestrogen Receptor Biology in Breast Cancer Susceptibility
Liu, Edison
Low, Y. L.
Li, Y.
Humphreys, K.
Thalamuthu, A.
Li, Y.
Darabi, H.
Wedren, S.
Bonnard, C.
Czene, K.
Iles, M.
Heikkinen, T.
Aittomaki, K.
Blomqvist, C.
Nevanlinna, H.
Hall, P.
Liu, J.
JOURNAL OF MEDICAL GENETICS, 2010, 47 : S33 - S33
[8] Identification of Novel Breast Cancer Risk Loci
Chan, Claire Hian Tzer
Munusamy, Prabhakaran
Loke, Sau Yeen
Koh, Geok Ling
Wong, Edward Sern Yuen
Law, Hai Yang
Yoon, Chui Sheun
Tan, Min-Han
Yap, Yoon Sim
Ang, Peter
Lee, Ann Siew Gek
CANCER RESEARCH, 2017, 77 (19) : 5428 - 5437
[9] Genome wide identification of susceptibility loci in breast cancer survival
Jeon, Sujee
Sung, Hyuna
Choi, Ji-Yeob
Song, Minkyo
Park, Sue K.
Yoo, Keun-Young
Noh, Dong-Young
Han, Wonsik
Ahn, Sei-Hyun
Kang, Daehee
CANCER RESEARCH, 2012, 72
[10] Genetic Susceptibility Loci for Breast Cancer by Estrogen Receptor Status
Garcia-Closas, Montserrat
Chanock, Stephen
CLINICAL CANCER RESEARCH, 2008, 14 (24) : 8000 - 8009

← 1 2 3 4 5 →